• News
  • SAN DIEGO
  • Education

UCSD names dean of Skaggs School of Pharmacy

James H. McKerrow, M.D., Ph.D., will become the second dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego, the school announced Monday.

He will start July 1.

McKerrow will join UC San Diego from UC San Francisco, where he served as professor of pathology and director of the Center for Discovery and Innovation in Parasitic Diseases.

An expert in the area of neglected tropical diseases, McKerrow brings a wealth of experience in natural product research and drug discovery and development. His keen interest in these areas will help bring together cross-disciplinary researchers at UC San Diego and in the community – in global health, infectious diseases, biology and chemistry and drug development programs – all of which are of strategic importance to the Health Sciences and the UC San Diego campus.

McKerrow is an alumnus of UC San Diego where he earned his Ph.D. in biology in 1973, focusing on peptide chemistry and molecular genetics. He then went on to receive his M.D. from SUNY, Stony Brook with an internship in internal medicine.

He completed his residency in pathology at UCSF, where he was chief resident from 1979 to 1980. From 1980 to 1981, he continued at UCSF as a postdoctoral fellow and clinical instructor, moving on to become an assistant (1981-1987), associate (1987-93) and full professor (1993-present) in the Department of Pathology. From 2003 to 2012, he also served as vice chair for research and education in the Department of Pathology.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

Subscribe Today!